C, or aurasperone-C is not proved. The spore toxin may exert its effect through its Background -The fungus Aspergillus ability to diffuse rapidly into the lung lining fumigatus, whose spores are present fluid, diminish the macrophage oxidative ubiquitously in the air, causes a range of burst, and play a part in allowing A diseases in the human lung. A small mofumigatus to persist in the lung and manilecular weight (<10 kD) heat stable toxin fest its well known pathogenic effects. released from the spores of clinical and (Thorax 1997;52:796-801) environmental isolates of A fumigatus within minutes of deposition in aqueous Keywords: Aspergillus fumigatus, macrophage, gliotoxin, solution has previously been described. A fumagillin, helvolic acid, fumigaclavine-C, aurasperone-C. key effect of the toxin was to inhibit the oxidative burst of macrophages as measured by superoxide anion release. It was The fungus Aspergillus fumigatus is commonly hypothesised that the toxin was one of the found in the environment, its usual habitat commonly found A fumigatus hyphal tox-being dead or decaying organic matter. The ins such as gliotoxin. This inhibitor may fungus causes many human lung diseases 1 2 and be an important factor which allows the a major factor in determining the pathogenicity fungus to colonise the lung.
Methods
carried out to assess the effect of 0.01% (v/v) ethanol which was present in the highest  Oxidised gliotoxin, helvolic acid, and fuma-concentration of each toxin. gillin were from Sigma (Poole, Dorset, UK) and reduced gliotoxin was prepared by the method of Waring et al. 12 All solvents were  To determine whether gliotoxin, fumagillin, HPLC grade. In house bred adult Wistar rats were used throughout.
and helvolic acid were lethal to cells, 4×10 5 alveolar macrophages were incubated in 10 g/ ml of each toxin for one hour at 37°C. Following this incubation the percentage viability   Rats were killed by intraperitoneal injection of was determined by the trypan blue exclusion method. Euthatal (Rhone Merieux Ltd). The lungs were dissected free of the thoracic cavity and lavaged with 4×8 ml sequential volumes of saline at 37°C to obtain the alveolar macrophages which        () were >95% pure, the remainder being lymphocytes.
Analysis of A fumigatus diffusate by TLC to identify the presence of both oxidised and reduced gliotoxin was by a modification of the method of Richard et al.
14 Samples (10-20 l)    A FUMIGATUS  A single strain of A fumigatus was isolated were spotted onto a K6F silica-60 plate (Whatman, Cat. No 4861-820), including standards from the sputum of a patient with allergic bronchopulmonary aspergillosis. Spores were of oxidised and reduced gliotoxin (5-10 g of standard per spot). The A fumigatus diffusate obtained from cultures that were grown for 10 days at 30°C on malt agar. Spore suspensions was concentrated 50-fold by freeze drying before analysis. The plate was developed 14 cm were prepared in Hank's balanced salt solution (HBSS, Gibco) by gentle homogenisation. with each of the following solvents: solvent 1, dichloromethane:methanol (97:3 v/v); solvent Spore counts were performed using an improved Neubauer chamber. To obtain diffusate 2, chloroform:methanol (70:30 v/v). Plates were air dried with the gliotoxin visualised as the spores were incubated at a concentration of 10 8 /ml in HBSS at 37°C for one hour in an orange/brown spots using a spray containing 5% (w/v) silver nitrate in ethanol:H 2 O (95:5 orbital incubator. The soluble diffusate was passed through a Whatman number 1 filter v/v). paper followed by a 0.22 m sterile filter and stored at −20°C.
      A fumigatus diffusate (100 ml) was extracted    Superoxide anion was measured as previously with 25 ml of chloroform, ethyl acetate, or dichloromethane with shaking overnight. The described.
13 Briefly, the assay mixture comprised 1.5 ml HBSS containing 2 mg/ml dex-organic phase was removed, evaporated to dryness under vacuum, and re-dissolved in 100 l trose (Sigma) and 1 mg/ml cytochrome C (Sigma). Gliotoxin, fumagillin, and helvolic of either chloroform or dichloromethane for TLC analysis, re-dissolved in 500 l of methacid (Sigma) were dissolved in ethanol at a concentration of 1 mg/ml and stored at −20°C. anol:H 2 O (50:50 v/v) for high performance liquid chromatography (HPLC) analysis or Each toxin was added to the assay in 10-fold dilutions to give final concentrations of 1 ng/ 1 ml of HBSS for the superoxide anion assay. ml to 10 g/ml. In a fourth series of experiments gliotoxin, fumagillin, and helvolic acid were added in paired combinations and also as a     A modification of the method of Richard et al 14 triplicate to see if more than one toxin had to be present to provoke an inhibitory response. was used to analyse A fumigatus diffusate for the presence of oxidised and reduced gliotoxin. In a final series of experiments spore diffusate which had been extracted with chloroform or The HPLC was from LKB-Pharmacia fitted with a Spherisorb Spheri-5 RP-18 reversed dichloromethane was added to give a final concentration of extraction products that would phase column (220×2.1 mm, 5 m) with an RP-18 Newguard (15×3.2 mm, 7 m) guard be found in an equivalent one quarter dilution of the unfractionated diffusate. Broncho-column. The mobile phase was methanol:H 2 O (50:50 v/v). Samples were dissolved in the alveolar macrophages (0.25×10 6 ) were added to each assay tube and triggered with phorbol mobile phase and 20 l injected onto the column at a flow rate of 0.1 ml/min with a demyristate acetate (PMA) (final concentration 1 g/ml; Sigma). Superoxide dismutase (SOD) tection wavelength of 275 nm. All samples and solvents were filtered through a 0.2 m filter controls (final concentration 38 g/ml; Sigma) were included in each assay. All assays were before use. performed in triplicate and incubated at 37°C for one hour. The supernatants were then read at 550 nm and 468 nm as previously described 10     - This was carried out by a modification of the and expressed as nanomoles of superoxide anion produced/10 chloromethane, 0.5 g of spores were soaked for 17 Briefly, a spore suspension was methanol (70:30 v/v) oxidised gliotoxin gave heated with an equal volume of chloroform an Rf of 0.97 while unfractionated A fumigatus and filtered through cheesecloth and through diffusate showed no spots. anhydrous sodium sulphate. The chloroform was removed and the precipitate resuspended in ethyl acetate. This was partitioned three
Reduced gliotoxin times in water adjusted to pH 2.0 with HCl.
In the solvent system dichloromethane:methThis was adjusted to pH 10.0 with sodium anol (97:3 v/v) standard reduced gliotoxin did carbonate and partitioned three times with not move from the origin. In the solvent chlorochloroform. The extract was dried over sodium form:methanol (70:30 v/v) reduced gliotoxin carbonate and concentrated under vacuum. A gave an Rf of 0.93. Unfractionated A fumigatus 2.5×10 cm neutral alumina column (dediffusate showed no spots corresponding to activated to activity grade IV) was equilibrated reduced gliotoxin, all the material remaining in benzene. The concentrate was loaded onto at the origin. the column and eluted with benzene. HPTLC was carried out on plates (LHP-KF; 10×10 cm) and developed in toluene:ethyl Solvent extraction acetate:formic acid (5:4:1). Visualisation was After extraction of A fumigatus diffusate with by spraying with 50% ethanolic H 2 SO 4 and ethyl acetate and development in the solvent heating for five minutes at 100°C. Fumigasystems dichloromethane:methanol (97:3 v/v) clavine-C was observed as a blue spot with and chloroform:methanol (70:30 v/v), no spots Rf=0.14. Commercial standards of fumigacorresponding to oxidised or reduced gliotoxin clavine-C are not available, so the above prowere observed. After extraction of A fumigatus cedure was also carried out using the fungal diffusate with chloroform, four major spots mycelium. This is a rich source of clavine were seen at Rf 0.48, 0.45, 0.19, and 0.08 alkaloids and a spot at Rf=0.14 corresponding (there were also three minor spots at Rf <0.08). to fumigaclavine-C was observed.
Both 
  
Gliotoxin showed no inhibitory effect at any dilution on superoxide anion production by rat alveolar macrophages. A significant stimulation was, however, detected at 100 ng/ml (table 2) . Both fumagillin and helvolic acid showed a significant decrease in superoxide production only at the highest dose of 10 g/ml. On as- 74%, thus explaining the decrease found only at the highest concentration of both fumagillin and helvolic acid. This effect was not found with gliotoxin, suggesting that it may offer some Reduced gliotoxin Reduced gliotoxin has a retention time of 4.5 protection from the effects of ethanol. When gliotoxin, fumagillin, and helvolic acid were minutes. There was no corresponding peak at this time after HPLC of A fumigatus diffusate. added in paired combinations or as mixtures of all three, no inhibition of superoxide anion was observed. All combinations where gliotoxin was present showed a significant increase Solvent extraction Extraction of A fumigatus diffusate with chloro-(p<0.05) in superoxide anion production (data not shown), as found in the previous exform gave several peaks with a major peak at a retention time of 19.3 minutes but no peak periments. There was no inhibitory effect of the unfractionated chloroform or dichloromethane corresponding to oxidised gliotoxin. There appear to be two peaks with retention times sim-spore extracts enriched for fumigaclavine-C or aurasperone-C, respectively (table 3) . ilar to reduced gliotoxin. However, this is unlikely to be reduced gliotoxin since none was detected in the A fumigatus diffusate by TLC. No peaks were seen for A fumigatus diffusate  When macrophages were treated with 10 g/ml extracted with ethyl acetate (results not shown) which is again in agreement with TLC analysis. of commercially obtained gliotoxin, fumagillin, and helvolic acid there was no evidence of lethality or loss of membrane integrity compared with untreated macrophages (data not Fumagillin, fumigaclavine-C, aurasperone-C A single peak with a retention time of 12.0 shown), as shown by trypan blue exclusion. minutes was seen after HPLC for standard fumagillin (data not shown), with no corresponding peak in the unfractionated A fu-Discussion
Reports on the effect of the A fumigatus spore migatus diffusate or in the chloroform extract. Neither aurasperone-C nor fumigaclavine-C diffusate on inhibition of phagocyte migration, spreading, and the oxidative burst have been were found in the spore diffusate by HPTLC, but both were present in the mycelial extracts numerous. [5] [6] [7] In addition, the hyphae of A fumigatus release an inhibitor of the com-(data not shown).
group.bmj.com on June 22, 2017 -Published by http://thorax.bmj.com/ Downloaded from plement system, the other key defence system of the toxins gliotoxin, helvolic acid, fumagillin, fumigaclavine-C, and aurasperone-C are found of the alveolar region of the lung. 18 Previous studies have demonstrated the presence of an in the spore diffusate, neither do commercial preparations or organic extracts (which should inhibitor of the macrophage oxidative burst that is present on all A fumigatus spores studied contain the toxins if present) of spores or hyphae inhibit the macrophage oxidative and is released from the surface of the spore.
10
The toxin is removed rapidly from the spore burst. It appears, therefore, that the immunomodulating effects of the spore diffusate, surface (within two minutes), is heat stable to 100°C, is of low molecular weight (<10 kD), including inactivation of the cytokine transcription factor NF-B 27 and inhibition of the and appears to be associated with a carbohydrate component of the diffusate. 10 oxidative burst, 10 are not caused by these toxins but are the result of the action of a novel spore The hyphae of A fumigatus have been found to release a number of other low molecular product. Enhanced binding of the A fumigatus spores in inflamed lung 28 may assist in bringing weight toxins -specifically gliotoxin, helvolic acid, and fumagillin 19 -and it has been reported the spore toxin into close contact with lung cells. that the toxins fumigaclavine-C and aurasperone-C are also associated with the fungal In summary, a small molecular weight toxin (<10 kD) that is released from the spores of a conidia. 20 Hyphal gliotoxin 21 is believed to be an important factor in allowing the hyphae to clinical isolate of A fumigatus within minutes of deposition in aqueous solution, which is grow in tissue. Gliotoxin is able dramatically to modulate lung cell functions such as at-capable of inhibiting the oxidative burst of macrophages without causing cell death, 10 is tachment of epithelial cells and fibroblasts as well as inhibiting phagocytosis by macrophages; distinct from common fungal toxins, particularly gliotoxin. Further research will be other important functions of the host immune defence are also impaired by gliotoxin, in-focused on molecular characterisation of the A fumigatus diffusate toxin and elaboration of its cluding induction of cytotoxic and alloreactive T cells. 22 Aurasperone-C, fumigaclavine-C, effect on intracellular signalling pathways in macrophages that leads to activation of the helvolic acid, and fumagillin have not been reported to have direct toxic effects on macro-NADPH oxidase complex and cytokine gene expression. [29] [30] [31] phages, but they do elicit severe clinical effects. Aurasperone-C is a tremerogen causing nervous system dysfunction. 17 Fumigaclavine-C is reduced form synthesised chemically in vitro. 
